BGN (biglycan) is a member of the leucine-rich small proteoglycan family; it can enhance the invasion, migration, and formation of endometrial cancer cells [36], and it can promote the invasion of GC cells by activating the FAK signaling pathway [37]. This evidence concerns the gene PTK2 and gastric cancer.